Highlights and Quick Summary
- EBT for the quarter ending February 28, 2023 was $-5.55 Million (a -246.65% decrease compared to previous quarter)
- Year-over-year quarterly EBT increased by 184.36%
- Annual EBT for 2022 was $-11.3 Million (a -89.04% decrease from previous year)
- Annual EBT for 2021 was $-103 Million (a -5.49% decrease from previous year)
- Annual EBT for 2020 was $-109 Million (a 2361.39% increase from previous year)
- Twelve month EBT ending February 28, 2023 was $-8.77 Million (a 35.34% increase compared to previous quarter)
- Twelve month trailing EBT decreased by -68.66% year-over-year
Trailing EBT for the last four month:
28 Feb '23 | 30 Nov '22 | 31 Aug '22 | 31 May '22 |
---|---|---|---|
$-8.77 Million | $-6.48 Million | $-11.3 Million | $-28 Million |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBT of Organigram Holdings Inc.
Most recent EBTof OGI including historical data for past 10 years.Interactive Chart of EBT of Organigram Holdings Inc.
Organigram Holdings Inc. EBT for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | $-5.55 | – | – | – | – |
2022 | $3.78 | $-5.05 | $-1.95 | $-3.26 | $-11.3 |
2021 | $-1.04 | $-21.72 | $-3.2 | $-52.09 | $-103.09 |
2020 | $-26.08 | $-31.41 | $-71.45 | $-5.72 | $-109.08 |
2019 | $-0.5 | $-22.24 | $-9.27 | $-5.26 | $-4.43 |
2018 | – | – | $32.34 | $2.52 | $21.75 |
2017 | – | – | – | – | $-8.51 |
2016 | – | – | – | – | $0.65 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic